Nitric oxide as a mediator of bone marrow fibrosis in patients with myelofibrosis

被引：0
|
作者：
Tabarroki, Ali [1 ]
Lindner, Daniel J. [1 ]
Visconte, Valeria [1 ]
Rogers, Heesun J. [2 ]
Tiu, Ramon V. [1 ,3 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA
[2] Cleveland Clin, Dept Clin Pathol, Cleveland, OH 44106 USA
[3] Cleveland Clin, Taussig Canc Inst, Leukemia Program, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44106 USA
来源：
NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 2014年 / 42卷
关键词：
D O I：
10.1016/j.niox.2014.09.137
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P196
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [1] Nitric Oxide As a Mediator of Bone Marrow Fibrosis in Patients with Myelofibrosis
    Tabarroki, Ali
    Lindner, Daniel
    Visconte, Valeria
    Papandantonakis, Nikolaos
    Ai, Jing
    Sekeres, Mikkael A.
    Advani, Anjali S.
    Kalaycio, Matt E.
    Cinalli, Tracy
    Colaluca, Kristin
    Rupp, Gina
    Desamito, John
    Rogers, Heesun J.
    Tiu, Ramon V.
    BLOOD, 2014, 124 (21)
  • [2] Prognostic Implications and Clinical Characteristics Associated with Bone Marrow Fibrosis in Patients with Myelofibrosis
    Nazha, Aziz
    Estrov, Zeev
    Cortes, Jorge E.
    Pierce, Sherry
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    BLOOD, 2011, 118 (21) : 1217 - 1217
  • [3] Prognostic implications and clinical characteristics associated with bone marrow fibrosis in patients with myelofibrosis
    Nazha, Aziz
    Estrov, Zeev
    Cortes, Jorge
    Bueso-Ramos, Carlos E.
    Kantarjian, Hagop
    Verstovsek, Srdan
    LEUKEMIA & LYMPHOMA, 2013, 54 (11) : 2537 - 2539
  • [4] The prognostic impact of bone marrow fibrosis in primary myelofibrosis
    Guglielmelli, Paola
    Vannucchi, Alessandro M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (10) : E454 - E455
  • [5] Contribution of comorbidities and grade of bone marrow fibrosis to the prognosis of survival in patients with primary myelofibrosis
    Lekovic, Danijela
    Gotic, Mirjana
    Perunicic-Jovanovic, Maja
    Vidovic, Ana
    Bogdanovic, Andrija
    Jankovic, Gradimir
    Cokic, Vladan
    Milic, Natasa
    MEDICAL ONCOLOGY, 2014, 31 (03)
  • [6] Contribution of comorbidities and grade of bone marrow fibrosis to the prognosis of survival in patients with primary myelofibrosis
    Danijela Lekovic
    Mirjana Gotic
    Maja Perunicic-Jovanovic
    Ana Vidovic
    Andrija Bogdanovic
    Gradimir Jankovic
    Vladan Cokic
    Natasa Milic
    Medical Oncology, 2014, 31
  • [7] Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies
    Abou Zahr, Abdallah
    Salama, Mohamed E.
    Carreau, Nicole
    Tremblay, Douglas
    Verstovsek, Srdan
    Mesa, Ruben
    Hoffman, Ronald
    Mascarenhas, John
    HAEMATOLOGICA, 2016, 101 (06) : 660 - 671
  • [8] Bone marrow fibrosis in primary myelofibrosis: the role of MMPs and TIMPs
    Dinca, M.
    Bulf, R. -Z.
    Harsan, P.
    Sticlaru, L.
    VIRCHOWS ARCHIV, 2019, 475 : S115 - S115
  • [9] Endothelial nitric oxide synthase of the bone marrow regulates myocardial hypertrophy, fibrosis, and angiogenesis
    Kazakov, Andrey
    Mueller, Patrick
    Jagoda, Philippe
    Semenov, Alexander
    Boehm, Michael
    Laufs, Ulrich
    CARDIOVASCULAR RESEARCH, 2012, 93 (03) : 397 - 405
  • [10] The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis
    Gianelli, Umberto
    Vener, Claudia
    Bossi, Anna
    Cortinovis, Ivan
    Iurlo, Alessandra
    Fracchiolla, Nicola S.
    Savi, Federica
    Moro, Alessia
    Grifoni, Federica
    De Philippis, Chiara
    Radice, Tommaso
    Bosari, Silvano
    Deliliers, Giorgio Lambertenghi
    Cortelezzi, Agostino
    MODERN PATHOLOGY, 2012, 25 (09) : 1193 - 1202
12345